These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

87 related articles for article (PubMed ID: 23215823)

  • 1. A dedicated GvHD clinic may improve the quality of life for allogeneic stem cell transplant survivors.
    Dignan FL; Manwani R; Potter MN; Ethell ME; Leonard H; Brennan J; Baker J; Shaw BE
    Clin Transplant; 2013; 27(1):E1-2. PubMed ID: 23215823
    [No Abstract]   [Full Text] [Related]  

  • 2. Feasibility study of a telehealth delivered, psychoeducational support group for allogeneic hematopoietic stem cell transplant patients.
    Lounsberry JJ; Macrae H; Angen M; Hoeber M; Carlson LE
    Psychooncology; 2010 Jul; 19(7):777-81. PubMed ID: 19653332
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Impact of GvHD on quality of life in long-term survivors of haematopoietic transplantation.
    Pallua S; Giesinger J; Oberguggenberger A; Kemmler G; Nachbaur D; Clausen J; Kopp M; Sperner-Unterweger B; Holzner B
    Bone Marrow Transplant; 2010 Oct; 45(10):1534-9. PubMed ID: 20228854
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Allogeneic stem cell transplantation as treatment for heavily treated, refractory acute graft-versus-host disease after HLA-mismatched stem cell transplantation.
    Ikegame K; Yoshihara S; Taniguchi Y; Kaida K; Inoue T; Okada M; Taniguchi K; Hasei H; Tamaki H; Fujioka T; Kato R; Soma T; Ogawa H
    Exp Hematol; 2011 Aug; 39(8):880-90. PubMed ID: 21689724
    [TBL] [Abstract][Full Text] [Related]  

  • 5. How can we improve life expectancy and quality of life in long-term survivors after allogeneic stem cell transplantation?
    Savani BN
    Semin Hematol; 2012 Jan; 49(1):1-3. PubMed ID: 22221778
    [No Abstract]   [Full Text] [Related]  

  • 6. Cotransplantation of mesenchymal stem cells might prevent death from graft-versus-host disease (GVHD) without abrogating graft-versus-tumor effects after HLA-mismatched allogeneic transplantation following nonmyeloablative conditioning.
    Baron F; Lechanteur C; Willems E; Bruck F; Baudoux E; Seidel L; Vanbellinghen JF; Hafraoui K; Lejeune M; Gothot A; Fillet G; Beguin Y
    Biol Blood Marrow Transplant; 2010 Jun; 16(6):838-47. PubMed ID: 20109568
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Allogeneic peripheral blood stem cell transplantation with CD34+-cell selection and delayed T-cell add-back in adults. Results of a single center pilot study.
    Martino R; Martín-Henao G; Sureda A; Altés A; Canals C; Brunet S; Sierra J
    Haematologica; 2000 Nov; 85(11):1165-71. PubMed ID: 11064469
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Acute graft versus host disease: a retrospective analysis of 55 bone marrow transplant patients].
    Bonavita K; Marsullo M; Rasero L
    Assist Inferm Ric; 2002; 21(4):193-7. PubMed ID: 12674031
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Chronic graft versus host disease.
    Higman MA; Vogelsang GB
    Br J Haematol; 2004 May; 125(4):435-54. PubMed ID: 15142114
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Quality of life associated with acute and chronic graft-versus-host disease.
    Lee SJ; Kim HT; Ho VT; Cutler C; Alyea EP; Soiffer RJ; Antin JH
    Bone Marrow Transplant; 2006 Aug; 38(4):305-10. PubMed ID: 16819438
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Quality of life and recovery after graft-versus-host disease.
    Baker KS; Fraser CJ
    Best Pract Res Clin Haematol; 2008 Jun; 21(2):333-41. PubMed ID: 18503996
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Graft-versus-host disease after allogeneic stem cell transplantation: evolving concepts and novel therapies including photopheresis.
    Komanduri KV; Couriel D; Champlin RE
    Biol Blood Marrow Transplant; 2006 Jan; 12(1 Suppl 2):1-6. PubMed ID: 16399595
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evidence that donor intrinsic response to G-CSF is the best predictor of acute graft-vs-host disease following allogeneic peripheral blood stem cell transplantation.
    Dhédin N; Chamakhi I; Perreault C; Roy DC; Sauvageau G; Ducruet T; Busque L; Fish D; Bélanger R; Roy J
    Exp Hematol; 2006 Jan; 34(1):107-14. PubMed ID: 16413397
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Paternity wishes in long-term survivors after allogeneic hematopoietic SCT. A study of the late effects working party of the EBMT.
    Rovó A; Aljurf M; Chiodi S; Spinelli S; Salooja N; Sucak G; Hunter A; Kim TS; Socié G; van Lint MT; Passweg JR; Arat M; Badoglio M; Tichelli A
    Bone Marrow Transplant; 2013 Jun; 48(6):878-9. PubMed ID: 23292242
    [No Abstract]   [Full Text] [Related]  

  • 15. [Risk factors of graft-versus-host disease in patients after allogeneic stem cell transplantation].
    Kozak I; Dwilewicz-Trojaczek J; Siemińska J; Górska R
    Wiad Lek; 2011; 64(3):164-9. PubMed ID: 22335138
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Early-onset lichenoid graft-vs.-host disease: a unique variant of acute graft-vs.-host disease occurring in peripheral blood stem cell transplant recipients.
    Magro CM; Kerns MJ; Votava H; Vasil KE; Dyrsen ME; Morrison CD
    J Cutan Pathol; 2010 May; 37(5):549-58. PubMed ID: 19843195
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The anti-tumor effect of allogeneic bone marrow/stem cell transplant without graft vs. host disease toxicity and without a matched donor requirement?
    Har-Noy M; Slavin S
    Med Hypotheses; 2008; 70(6):1186-92. PubMed ID: 18054441
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Platelet gel for treatment of mucocutaneous lesions related to graft-versus-host disease after allogeneic hematopoietic stem cell transplant.
    Picardi A; Lanti A; Cudillo L; Cerretti R; Dentamaro T; De Angelis G; Ferraro A; Di Veroli A; Adorno G; Arcese W;
    Transfusion; 2010 Feb; 50(2):501-6. PubMed ID: 19821947
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Chronic graft-versus-host disease after allogeneic stem cell transplantation: challenges in prevention, science, and supportive care.
    Joseph RW; Couriel DR; Komanduri KV
    J Support Oncol; 2008; 6(8):361-72. PubMed ID: 19149321
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Quality of life following bone marrow transplantation: a comparison of patient reports with population norms.
    Sutherland HJ; Fyles GM; Adams G; Hao Y; Lipton JH; Minden MD; Meharchand JM; Atkins H; Tejpar I; Messner HA
    Bone Marrow Transplant; 1997 Jun; 19(11):1129-36. PubMed ID: 9193757
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.